Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Wound Assessment Using Spectral Imaging US

ClinicalTrials.gov ID: NCT05415683

Public ClinicalTrials.gov record NCT05415683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 9:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

During the observational, non-interventional study, at Baseline Study Visit (BSV) subjects will be screened and consented. Eligible subjects will undergo imaging with the DeepView device. Pre- and post-debridement images will be obtained (if debridement performed per SOC), as well as reviewing medical history and physical assessments. Additional Study Visits (SVs) will be performed when patient returns to the clinic for Routine Clinic Visit for up to 12 weeks or wound closure. During these visits DeepView imaging will occur pre- and post-debridement, and the status of the subject's treatment will be recorded.

Study identification

NCT ID
NCT05415683
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
SpectralMD
Industry
Enrollment
400 participants

Conditions and interventions

Interventions

Diagnostic Test

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 22, 2022 (Actual)
Primary completion
Jun 28, 2024 (Actual)
Completion
Aug 30, 2024 (Actual)
Last update posted
Nov 8, 2024

2022 – 2024

United States locations

U.S. sites
11
U.S. states
5
U.S. cities
11
Facility City State ZIP Site status
Surgery of Foot and Ankle Encino California 91316 —
New Hope Podiatry Group Los Angeles California 90063 —
Northwell Hospital Lake Success New York 11042 —
Cutting Edge Research LLC Circleville Ohio 43920 —
Gentle Foot Care Grove City Ohio 43123 —
Gentle Foot Care Hilliard Ohio 43026 —
Foot and Ankle Specialist of Ohio Mentor Ohio 44060 —
Worthington Foot and Ankle Worthington Ohio 43085 —
Lower Extremity Institute of Research & Therapy (LEIRT) Youngstown Ohio 44512 —
University of Tennessee Health Science Center, Wound Care Center @ Regional One Memphis Tennessee 38103 —
West Houston Foot and Ankle Missouri City Texas 77459 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05415683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 8, 2024 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05415683 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →